During the forecast period 2023 to 2033, the molybdenum cofactor deficiency type-A (MoCoD-A) treatment market is expected to grow at a value of 12% CAGR, according to Future Market Insights. By the year 2033, the global market for Molybdenum cofactor deficiency type-A (MoCoD-A) treatment is expected to rise up to a market valuation of US$ …